Clinical trial

Low Dose Fat-Induced Insulin Resistance

NCT03479671

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-01-01

PhaseEARLY_PHASE1

Study timeline

Study start (actual)2020-01-01Date precision: day

Registry last updated2026-04-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Insulin Resistanceunresolved

Insulin Sensitivityunresolved

Interventions

Intralipid, 20% Intravenous EmulsionDRUG

Sponsors & collaborators

University of Pennsylvanialead sponsor

Mapped research locations

PhiladelphiaPennsylvania, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03479671 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.